Escitalopram (Lexapro) has been consistently shown to be the most effective and tolerable SSRI on the market. It’s been shown to be more effective and tolerable than other SSRIs and some SNRIs. Lexapro could be more efficacious due to its interaction with orthosteric and allosteric binding sites at the serotonin transporter. And because it’s the most selective SSRI on the market.
Here are some studies showing this.
This published review study states the following:
“These analyses are in favor of a superior efficacy and tolerability of long-term escitalopram treatment (10 to 20mg/day) compared with active controls, including selective serotonin re-uptake inhibitors (SSRIs) (paroxetine, citalopram, bupropion, fluoxetine, fluvoxamine, sertraline), serotonin/noradrenaline reuptake inhibitors (SNRIs) (venlafaxine, milnacipran and duloxetine) and noradrenergic and specific serotonergic antidepressants (NaSSAs) (mirtazapine).”
“In all these meta-analyses, the superiority of escitalopram compared with other antidepressants was confirmed for both acute and long-term treatment of MDD, especially in harshly depressed patients.”
https://pubmed.ncbi.nlm.nih.gov/22381728/
This published meta analysis study that compares Lexapro to several SSRIs and the SNRI Effexor states:
“In this meta-analysis, escitalopram showed significant superiority in efficacy compared with the active controls.”
https://pubmed.ncbi.nlm.nih.gov/16575428/
This published review study states:
“A significant advantage for escitalopram has been reported in randomized, double-blind, short-term studies compared with citalopram, paroxetine and duloxetine. [Cymbalta]”
“There were significantly more responders on escitalopram (74%) than comparators (63%). Both of these measures demonstrate a clinically relevant difference in favour of escitalopram.”
https://pubmed.ncbi.nlm.nih.gov/19357527/
This published review study states:
“There is evidence that escitalopram is more effective than a range of other antidepressants.”
“Overall, as an allosteric serotonin reuptake inhibitor that is somewhat different from classical SSRIs, escitalopram is the first choice judged by combined efficacy and tolerability”
https://pubmed.ncbi.nlm.nih.gov/24424469/
This systematic review and meta analysis study mentions Lexapro to be more effective and tolerable than many other antidepressants. It states:
“In head-to-head studies, agomelatine, amitriptyline, escitalopram, mirtazapine, paroxetine, venlafaxine, and vortioxetine were more effective than other antidepressants, whereas fluoxetine, fluvoxamine, reboxetine, and trazodone were the least efficacious drugs.
For acceptability, agomelatine, citalopram, escitalopram, fluoxetine, sertraline, and vortioxetine were more tolerable than other antidepressants, whereas amitriptyline, clomipramine, duloxetine, fluvoxamine, reboxetine, trazodone, and venlafaxine had the highest dropout rates.”
https://pubmed.ncbi.nlm.nih.gov/29477251/
Just to note, Lexapro being the best SSRI won’t be true for everyone as everyone reacts differently to meds. However, the research consistently shows Lexapro to be more effective and tolerable than many other antidepressants including all of the SSRIs and some SNRIs like Effexor and Cymbalta.